Clinical Review

Drug Class Suffixes: The NCLEX Decoder Chart

Drug suffixes are pattern shortcuts: the ending of a generic name often tells you the drug class, which tells you the mechanism, side effects, and the nursing watch-points. On the NCLEX, “-pril” points to an ACE inhibitor (watch the dry cough and hyperkalemia), “-olol” to a beta-blocker (hold for a heart rate under 60), “-statin” to a cholesterol drug (watch for muscle pain), and so on. The decoder table below maps common high-yield suffixes to their class, an example drug, and the one nursing concern most likely to show up in a question — but read the warning first: these endings are reliable guides, not laws.

The drug suffix decoder chart

Learn the suffix, then the class, then the single most-tested nursing concern attached to that class. That chain is what lets you reason through an unfamiliar drug name on exam day. The most heavily tested cardiovascular suffixes sit at the top because that is where the NCLEX concentrates its fire.

Suffix Drug class Example drug(s) Key use + top nursing concern
-pril ACE inhibitors lisinopril, enalapril, captopril, ramipril Hypertension, heart failure. Dry, hacking cough; hyperkalemia; first-dose hypotension; angioedema (stop the drug, assess the airway).
-sartan ARBs (angiotensin II receptor blockers) losartan, valsartan, olmesartan Hypertension, heart failure — often used when an ACE inhibitor’s cough is intolerable. Still causes hyperkalemia; far less cough. Avoid in pregnancy.
-olol Beta-blockers metoprolol, atenolol, propranolol, carvedilol Hypertension, angina, post-MI, heart failure. Hold and reassess if heart rate < 60 or systolic BP is low; never stop abruptly (rebound tachycardia/angina); masks the tachycardia of hypoglycemia.
-dipine Calcium channel blockers, dihydropyridine type amlodipine, nifedipine, felodipine Hypertension, angina. Peripheral edema, headache, reflex tachycardia, dizziness. These act mainly on vessels, not the heart’s conduction.
-statin HMG-CoA reductase inhibitors (statins) atorvastatin, simvastatin, rosuvastatin, pravastatin High cholesterol. Muscle pain/weakness is the red flag — report it because it can signal rhabdomyolysis (check CK, watch for dark urine). Check liver enzymes at baseline, then as clinically indicated; take simvastatin/lovastatin in the evening; avoid grapefruit.
-prazole Proton pump inhibitors (PPIs) omeprazole, pantoprazole, esomeprazole, lansoprazole GERD, ulcers, H. pylori regimens. Long-term use risks low magnesium, low B12, C. diff, and fracture; take before the first meal of the day.
-tidine H2-receptor blockers famotidine, cimetidine, nizatidine GERD, ulcers. Less potent acid suppression than PPIs. Cimetidine is the cautious one — many drug interactions and possible confusion in older adults.
-pam / -lam Benzodiazepines lorazepam, diazepam, clonazepam, alprazolam, midazolam Anxiety, seizures, alcohol withdrawal, sedation. Watch respiratory depression and sedation, especially with opioids or alcohol; high dependence risk; do not stop abruptly. Antidote: flumazenil.
-barbital Barbiturates phenobarbital, pentobarbital, secobarbital Seizures, sedation. Narrow safety margin and pronounced respiratory depression; strong CNS depressant; high abuse potential. No specific reversal agent — support the airway.
-caine Local anesthetics lidocaine, bupivacaine, procaine, benzocaine Local/regional anesthesia (lidocaine also treats some ventricular dysrhythmias). Systemic toxicity causes CNS effects (perioral numbness, tremors, seizures) then cardiac toxicity; benzocaine sprays can cause methemoglobinemia.
-cillin Penicillins amoxicillin, ampicillin, penicillin G, nafcillin, piperacillin Bacterial infections. Always screen for penicillin allergy and cross-reactivity with cephalosporins; watch for anaphylaxis and rash.
-mycin / -micin Aminoglycosides (imperfect — see note) gentamicin, tobramycin, amikacin, neomycin Serious gram-negative infections. Nephrotoxic and ototoxic — monitor BUN/creatinine, peaks and troughs, and hearing/balance. Caution: “-mycin” also ends some macrolides (azithromycin, clarithromycin) and vancomycin, which are different classes. This suffix is the least reliable on the list.
-floxacin Fluoroquinolones ciprofloxacin, levofloxacin, moxifloxacin Broad-spectrum infections. Tendon rupture (especially Achilles, worse with steroids and in older adults); QT prolongation; photosensitivity; avoid taking with antacids, calcium, iron, or dairy that bind the drug.
-cycline Tetracyclines doxycycline, minocycline, tetracycline Acne, atypical and tick-borne infections. Photosensitivity; do NOT give with dairy, antacids, or iron (they chelate the drug); stains developing teeth, so avoid in children under 8 and in pregnancy — the exception is doxycycline for suspected tick-borne rickettsial illness such as Rocky Mountain spotted fever, which the CDC recommends at any age because delaying treatment can be fatal.
-terol Beta-2 agonists (bronchodilators) albuterol, salmeterol, levalbuterol, formoterol Asthma, COPD. Tremor, tachycardia, palpitations, nervousness. Albuterol is the short-acting rescue inhaler; salmeterol/formoterol are long-acting and never used alone for asthma rescue.
-parin Low-molecular-weight heparins (LMWH) enoxaparin, dalteparin VTE prevention/treatment (unfractionated heparin also ends in “-parin” but is aPTT-monitored and more fully reversed by protamine). LMWH: subcutaneous, given in the abdomen (don’t expel the air bubble, don’t aspirate, don’t rub); watch for bleeding and HIT. Partially reversed by protamine sulfate.
-plase Thrombolytics (“clot busters”) alteplase (tPA), reteplase, tenecteplase Acute ischemic stroke, STEMI, massive PE. Major bleeding is the danger — strict time windows and contraindication screening (recent surgery, bleeding, uncontrolled hypertension); monitor neuro status closely. (Note: a bare “-ase” only signals a generic enzyme — amylase, lipase — so the specific tissue-plasminogen-activator cue is “-plase”/”-teplase,” not “-ase” alone.)

Read this before you trust a suffix: they are guides, not rules

A drug suffix is a strong hint, not a guarantee. The naming convention (the “stem” assigned by the United States Adopted Names council) is meant to group related drugs, and most of the time it does. But there are real exceptions, and the NCLEX writes distractors that exploit them. Use suffixes to generate a fast hypothesis, then confirm with what you actually know about the drug.

The classic traps to keep in your back pocket:

  • “-mycin / -micin” is the worst offender. Gentamicin, tobramycin, and amikacin are aminoglycosides (nephro- and ototoxic). But azithromycin and clarithromycin are macrolides, and vancomycin is a glycopeptide — completely different classes, different toxicities. Never assume “-mycin” means aminoglycoside; check the rest of the name.
  • “-ase” means enzyme, not specifically thrombolytic. A bare “-ase” only points to a generic enzyme — think amylase and lipase. The tissue-plasminogen-activator clot-busters carry the fuller ending “-plase” (alteplase, reteplase, tenecteplase), so that is the cue to trust, not “-ase” by itself.
  • “-pine” is too broad to be a single class. Amlodipine is a calcium channel blocker, but clozapine and olanzapine are antipsychotics. The reliable cardiac cue is the fuller ending “-dipine.”
  • Carvedilol and labetalol are beta-blockers that also block alpha-1 receptors, adding vasodilation (and more orthostatic hypotension). Strictly, neither ends in “-olol” (labetalol ends in “-alol,” the stem for combined alpha- and beta-blockers; carvedilol ends in “-ilol”), so read the broader “-lol” ending as the beta-blocker cue; just know these two do extra.
  • Lidocaine wears two hats. The “-caine” tells you it is a local anesthetic, but IV lidocaine is also an antiarrhythmic. Same molecule, different job depending on the route and dose.

Bottom line: a suffix narrows the field in two seconds. It does not replace knowing the drug. When a question hinges on a single right answer, verify the class with the drug’s actual action before you commit.

How do you use suffixes to answer a question faster?

Picture the stem giving you a drug you half-recognize, say “enalapril,” and asking which finding to report. You may not have memorized enalapril cold, but the “-pril” lands it in the ACE inhibitor box. From there the whole package unfolds: vasodilation, possible first-dose hypotension, the nagging dry cough, rising potassium, and the rare-but-deadly angioedema. The suffix did not give you the answer — your knowledge of the class did — but it told you which drawer to open.

This is exactly why grouping drugs by ending beats memorizing them one at a time. You are not learning 3,000 individual drugs; you are learning roughly two dozen classes and the handful of drugs that anchor each one. The suffix is the index card.

The cardiovascular cluster you cannot afford to miss

Blood-pressure and cardiac drugs are a high-yield medication group, and three suffixes do most of the work. “-pril” (ACE inhibitor) and “-sartan” (ARB) both act on the renin-angiotensin system, both raise potassium, both are avoided in pregnancy — the difference students must keep straight is that ACE inhibitors cause the dry cough and the rare angioedema, while ARBs largely do not. If a patient on lisinopril cannot tolerate the cough, the prescriber often switches them to losartan. “-olol” (beta-blocker) brings the heart rate down, which is why you check the apical pulse before giving it and hold for a rate under 60, and why you never let a patient stop it abruptly.

For a deeper walk through these drugs in the context of actual cardiac patients, our NCLEX cardiac review ties the mechanisms to the rhythms and conditions they treat.

The “watch the level” suffixes

Some classes flagged by their suffix are exactly the drugs you monitor with blood levels or organ-function labs. Aminoglycosides (“-mycin/-micin”) need peak and trough levels plus renal monitoring. Statins (“-statin”) need liver enzyme and CK awareness. Unfractionated heparin needs aPTT monitoring to keep it in the therapeutic window. These suffixes are a built-in reminder that a lab is attached. The full monitored ranges live in our therapeutic drug levels guide — pair it with this chart so that the moment you spot the suffix, the relevant lab comes to mind.

Low-molecular-weight heparin (“-parin,” enoxaparin and dalteparin) is the deliberate exception here. Unlike unfractionated heparin, LMWH does not require routine therapeutic-level (anti-Xa) monitoring in the typical patient — its dose is weight-based and its response predictable. What you watch instead is the patient: signs of bleeding, and the platelet count for heparin-induced thrombocytopenia (HIT). So group LMWH with the “watch the patient” drugs, not the “watch the level” ones; anti-Xa levels are reserved for special cases such as pregnancy, obesity, or renal impairment.

Learning drug class suffixes?
Put it to the test with NCLEX-style practice questions — free, full rationale on every answer. No credit card.

Start practicing →

Suffixes that point straight to an antidote

A few endings should immediately make you think about reversal. When you see “-pam” or “-lam” (benzodiazepine) and the question describes oversedation or respiratory depression, the named reversal agent is flumazenil — though it is used cautiously, not routinely. When you see “-parin” (LMWH) and active bleeding, think protamine sulfate (partial reversal for LMWH, fuller reversal for unfractionated heparin). The full set of poison-to-antidote pairings is in our antidotes and reversal agents guide; linking the suffix to its antidote closes the loop between recognizing the class and knowing the rescue.

Key takeaways

  • “-pril” = ACE inhibitor — watch the dry cough, hyperkalemia, first-dose hypotension, and angioedema.
  • “-sartan” = ARB — acts on the same RAAS pathway as ACE inhibitors (blocking the angiotensin II receptor instead of ACE) and still raises potassium, but without the cough; common substitute when “-pril” causes a cough.
  • “-olol” = beta-blocker — check the apical pulse, hold for HR < 60, never stop abruptly, and remember it masks the warning tachycardia of hypoglycemia.
  • “-dipine” = dihydropyridine calcium channel blocker — peripheral edema and headache; “-dipine,” not just “-pine,” is the reliable cue.
  • “-statin” = statin — muscle pain is the rhabdomyolysis red flag; check CK if muscle symptoms appear, and liver enzymes at baseline.
  • “-prazole” = PPI; “-tidine” = H2 blocker — both reduce stomach acid, PPIs more strongly; take PPIs before the first meal.
  • “-pam/-lam” = benzodiazepine (antidote flumazenil); “-barbital” = barbiturate (no specific reversal, support the airway).
  • “-cillin” = penicillin (screen for allergy); “-floxacin” = fluoroquinolone (tendon rupture); “-cycline” = tetracycline (photosensitivity, no dairy/antacids, avoid in kids and pregnancy).
  • “-terol” = beta-2 agonist (albuterol is rescue, salmeterol is long-acting maintenance); “-parin” = LMWH (subcutaneous, protamine partially reverses); “-plase” = thrombolytic (bleeding risk, strict time windows).
  • Suffixes are guides, not absolute rules. “-mycin” spans aminoglycosides AND macrolides plus vancomycin; “-ase” marks enzymes broadly; “-pine” is too vague. Confirm the class with the drug’s actual action before you answer.

Sample NCLEX questions

Sample question 1

A nurse is reviewing the medication list of a client newly prescribed lisinopril for hypertension. Which client complaint, if reported a week later, is most consistent with a common adverse effect of this drug class?

  1. A persistent dry, hacking cough
  2. Increased urinary frequency at night
  3. Yellow-green halos around lights
  4. A craving for salty foods
Show answer & rationale

Correct answer: A. The “-pril” suffix identifies lisinopril as an ACE inhibitor, and a dry, nonproductive cough is the hallmark adverse effect, caused by bradykinin buildup; it is the usual reason a client is switched to an ARB (“-sartan”). Nocturia points to a diuretic effect, not ACE inhibition. Yellow-green halos are a sign of digoxin toxicity. A salt craving is associated with adrenal insufficiency, not ACE inhibitors.

Sample question 2

Before administering the morning dose of metoprolol, the nurse assesses the client. Which finding requires the nurse to hold the medication and notify the provider?

  1. Blood pressure 138/86 mm Hg
  2. Apical heart rate of 52 beats/min
  3. Respiratory rate of 18 breaths/min
  4. Temperature of 99.1°F (37.3°C)
Show answer & rationale

Correct answer: B. The “-olol” suffix marks metoprolol as a beta-blocker, which slows heart rate; the nurse holds the dose and notifies the provider when the apical pulse is below 60. A blood pressure of 138/86 is mildly elevated, not a reason to hold a drug intended to lower it. A respiratory rate of 18 and a temperature of 99.1°F are within normal limits and unrelated to beta-blocker administration.

Sample question 3

A client taking atorvastatin calls the clinic reporting new, unexplained muscle aches and weakness in both thighs along with darkened urine. What is the nurse’s priority response?

  1. Reassure the client that muscle aches are expected and harmless
  2. Advise the client to double the next dose to overcome the symptom
  3. Instruct the client to be evaluated, anticipating a CK level
  4. Tell the client to switch the dose to the morning
Show answer & rationale

Correct answer: C. The “-statin” suffix identifies atorvastatin as an HMG-CoA reductase inhibitor, and new muscle pain with weakness and dark urine raises concern for rhabdomyolysis, a serious adverse effect; the client needs evaluation and a creatine kinase (CK) level. Dismissing the symptom as harmless ignores a potentially dangerous reaction. Doubling the dose would worsen the risk. Changing the timing addresses neither the symptom nor the urgency.

Sample question 4 (Select all that apply)

A nursing student is matching drug suffixes to their classes for an exam. Which suffix-to-class pairings are correct? Select all that apply.

  • A. “-floxacin” → fluoroquinolone
  • B. “-parin” → low-molecular-weight heparin
  • C. “-dipine” → ACE inhibitor
  • D. “-prazole” → proton pump inhibitor
  • E. “-terol” → beta-2 agonist
Show answer & rationale

Correct answers: A, B, D, E. “-floxacin” marks the fluoroquinolones (tendon rupture risk), “-parin” marks the low-molecular-weight heparins (subcutaneous anticoagulants), “-prazole” marks the proton pump inhibitors, and “-terol” marks the beta-2 agonist bronchodilators. Option C is the trap: “-dipine” identifies a dihydropyridine calcium channel blocker such as amlodipine, not an ACE inhibitor. ACE inhibitors carry the “-pril” suffix.

Frequently Asked Questions

Are drug suffixes always reliable for identifying a class?

No. Suffixes are strong guides, not absolute rules. Most generic names follow a naming convention that groups related drugs, but exceptions exist. The “-mycin” ending is the biggest trap because it appears in aminoglycosides (tobramycin), macrolides (azithromycin), and the glycopeptide vancomycin, which are three different classes with different toxicities. Use the suffix to form a quick guess, then confirm with what you know about the specific drug.

What is the difference between “-pril” and “-sartan” drugs?

Both act on the renin-angiotensin-aldosterone system and both are used for hypertension and heart failure, and both can raise potassium and are avoided in pregnancy. The key difference is that “-pril” drugs (ACE inhibitors) commonly cause a dry, hacking cough and, rarely, angioedema, while “-sartan” drugs (ARBs) largely do not. That is why a patient who cannot tolerate the cough from lisinopril is often switched to losartan.

How do I tell beta-blockers from beta-2 agonists since both relate to “beta”?

Look at the suffix, not the word “beta.” Beta-blockers end in “-olol” (metoprolol, atenolol) and slow the heart and lower blood pressure. Beta-2 agonists end in “-terol” (albuterol, salmeterol) and open the airways for asthma and COPD. They have nearly opposite cardiovascular effects: beta-blockers reduce heart rate, while beta-2 agonists can cause tremor and a faster heart rate.

Why does the “-mycin” suffix cause so much confusion?

Because it spans more than one class. Aminoglycosides such as gentamicin and tobramycin end in “-micin” or “-mycin” (amikacin, which ends in “-kacin,” is an exception) and are nephrotoxic and ototoxic, requiring renal and hearing monitoring plus peak and trough levels. But azithromycin and clarithromycin are macrolides, and vancomycin is a glycopeptide, all ending in “-mycin” with different profiles. Never assume “-mycin” automatically means aminoglycoside; verify the specific drug.

Should I memorize suffixes or individual drugs for the NCLEX?

Learn the suffixes first, because they let you collapse thousands of individual drugs into roughly two dozen classes. Once you know the class, the mechanism, common side effects, and key nursing actions usually follow. Then anchor each suffix with one or two example drugs you know well. The suffix is your index; the example drug is your reference point.

The fastest way to make these suffixes stick is to see them in real questions and read why each option is right or wrong. For the full picture on mechanisms and adverse effects behind every class, work through the NCLEX pharmacology review, then practice free NCLEX questions with full rationales — every answer explained, no credit card required.

Practice questions like these

Put it to the test with NCLEX-style practice questions — free, full rationale on every answer. No credit card.

Start Practicing Free

Sources

Sources checked September 2026.